Accessibility statement

Health Technology Assessment

We assess the effectiveness, costs and broader impact of health care interventions including tests, pharmaceuticals, devices and procedures to inform healthcare policy decisions.

Most of our HTA work is carried out as part of the NIHR Technology Assessment Reviews (TAR) Programme and the NIHR York Evidence Synthesis Group (ESG). Funded by the National Institute of Health and Care Research (NIHR) Evidence Synthesis Programme, these programmes enable rapid commissioning of HTAs including systematic reviews and economic evaluations to inform decision makers, including the National Institute for Health and Care Excellence (NICE) and NHS England.

Technology Assessment Reviews (TAR) Programme

This programme enables rapid commissioning of HTAs to support the development of NICE guidance and reimbursement decisions, and to support evidence needs of other policy makers.

York Evidence Synthesis Group

This programme funds research projects that identify, evaluate and combine data from existing research studies to provide best evidence, including the effectiveness and cost-effectiveness of treatments, tests, and other interventions, to support decision-making across health, public health and social care in all four nations of the UK.


In addition to these large programmes of work, we carry out further Health Technology Assessments funded by the NIHR HTA programme and other organisations.